Form 4: Cerus Corp Chief Legal Officer Sells Shares Under 10b5-1 Plan

Cerus Corporation's Chief Legal Officer, Chrystal Jensen, sold 16,667 shares of common stock at an average price of $1.71, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Chrystal Jensen, the Chief Legal Officer of Cerus Corporation, sold 16,667 shares of common stock on December 16, 2024.
• The sale was executed under a pre-arranged 10b5-1 trading plan.
• The shares were sold at a weighted average price of $1.71, with individual trades ranging from $1.675 to $1.735.
• Following the transaction, Ms. Jensen directly owns 457,578 shares of Cerus Corporation common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an insider stock sale under a pre-arranged plan. It doesn't indicate any positive or negative sentiment about the company's performance.

Risks

• Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned sale, which is a common practice to avoid accusations of trading on inside information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice among corporate executives to manage their stock sales and avoid accusations of insider trading.
• Similar filings are regularly made by executives at other publicly traded companies such as Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) when they execute pre-planned stock sales.

Stakeholder Impact

• The sale of shares by a company officer may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Cerus Corporation, insider trading, Form 4, 10b5-1 plan, stock sale, Chrystal Jensen, CERS